£82.50

Birkhauser Aromatase Inhibitors (Milestones in Drug Therapy)

Price data last checked 102 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

This is the usual price. Wait for it to drop, or tell us your number.

£83 today · usual range £0–£0 · best ever £78

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 629 days • 629 data points (No recent data available)

Historical
Generating forecast...
£90.24 £77.04 £79.92 £82.80 £85.68 £88.56 £91.44 09 June 2024 13 November 2024 19 April 2025 23 September 2025 27 February 2026

Price Distribution

Price distribution over 629 days • 10 price levels

Days at Price
Current Price
57 days 113 days 94 days 42 days 94 days · current 29 days 55 days 125 days 6 days 14 days 0 31 63 94 125 £78 £79 £80 £81 £82 £84 £86 £87 £88 £90 Days at Price

Price Analysis

Most common price: £87 (125 days, 19.9%)

Price range: £78 - £90

Price levels: 10 different prices over 629 days

Description

Many breast tumours are dependent upon oestrogen for their development and continued growth. Over the last 25 years, hormone therapy has progressed from the irreversible destruction of endocrine glands to the use of drugs that reversibly suppress oestrogen synthesis or action. The inhibition of oestrogen synthesis is most readily achieved by inhibiting the final step in the pathway of oestrogen biosynthesis, the reaction which transforms androgens into oestrogens by creating an aromatic ring in the steroid molecule (hence the enzyme's trivial name, aromatase). Whereas, the first aromatase inhibitors to be used therapeutically could be shown to produce drug-induced inhibition of the enzyme and therapeutic benefits in patients with breast cancer, they were not particularly potent and lacked specificity. However, second-generation drugs were developed and most recently third-generation inhibitors have evolved which possess remarkable specificity and potency. Initial results from clinical trials suggest that these agents will become the cornerstones of future endocrine therapy.

Product Specifications

Format
Hardcover
Domain
Amazon UK
Release Date
01 June 2005
Listed Since
18 December 2006

Barcode

No barcode data available

Similar Products You Might Like

Resistance to Aromatase Inhibitors in Breast Cancer: 8 (Resistance to Targeted Anti-Cancer Therapeutics, 8)
97% match

Resistance to Aromatase Inhibitors in Breast Cancer: 8 (Resistance to Targeted Anti-Cancer Therapeutics, 8)

Springer

£60.65 16 Mar 2026
Hormone Therapy in Breast and Prostate Cancer (Cancer Drug Discovery and Development)
96% match

Hormone Therapy in Breast and Prostate Cancer (Cancer Drug Discovery and Development)

Humana

£60.74 10 Mar 2026
Estrogen Receptor and Breast Cancer: Celebrating the 60th Anniversary of the Discovery of ER (Cancer Drug Discovery and Development)
95% match

Estrogen Receptor and Breast Cancer: Celebrating the 60th Anniversary of the Discovery of ER (Cancer Drug Discovery and Development)

Humana

£127.00 11 Jan 2026
Selective Estrogen Receptor Modulators: A New Brand of Multitarget Drugs
95% match

Selective Estrogen Receptor Modulators: A New Brand of Multitarget Drugs

Springer

£30.49 09 Mar 2026
Springer - New Molecular Mechanisms of Estrogen Action (Vol 46)
95% match

Springer - New Molecular Mechanisms of Estrogen Action (Vol 46)

Springer

£121.49 20 Apr 2026
Estrogens and Antiestrogens II: Pharmacology and Clinical Application of Estrogens and Antiestrogen: 135 / 2 (Handbook of Experimental Pharmacology, 135 / 2)
95% match

Estrogens and Antiestrogens II: Pharmacology and Clinical Application of Estrogens and Antiestrogen: 135 / 2 (Handbook of Experimental Pharmacology, 135 / 2)

Springer

£72.05 08 Mar 2026
Estrogens and Antiestrogens I: Physiology and Mechanisms of Action of Estrogens and Antiestrogens: 135 / 1 (Handbook of Experimental Pharmacology, 135 / 1)
94% match

Estrogens and Antiestrogens I: Physiology and Mechanisms of Action of Estrogens and Antiestrogens: 135 / 1 (Handbook of Experimental Pharmacology, 135 / 1)

Springer

£211.51 11 Jan 2026
Springer - Therapeutic Resistance to Anti-hormonal Drugs Book
94% match

Springer - Therapeutic Resistance to Anti-hormonal Drugs Book

Springer

£113.78 14 Apr 2026
Hormones and Cancer: Breast and Prostate, An Issue of Endocrinology and Metabolism Clinics of North America (Volume 40-3) (The Clinics: Internal Medicine, Volume 40-3)
94% match

Hormones and Cancer: Breast and Prostate, An Issue of Endocrinology and Metabolism Clinics of North America (Volume 40-3) (The Clinics: Internal Medicine, Volume 40-3)

Saunders

£61.52 05 Mar 2026
ESTROGEN RECEPTORS MECH.STRUCT: Mechanisms, Structure & Role in Disease (Protein Biochemistry, Synthesis, Structure and Cellular Functions)
94% match

ESTROGEN RECEPTORS MECH.STRUCT: Mechanisms, Structure & Role in Disease (Protein Biochemistry, Synthesis, Structure and Cellular Functions)

£137.69 06 Jan 2026
Biologie und Epidemiologie der Hormonersatztherapie - Biology and Epidemiology of Hormone Replacement Therapy: Diskussionen zur Postmenopausalen ... Foundation Symposium Proceedings, 13)
94% match

Biologie und Epidemiologie der Hormonersatztherapie - Biology and Epidemiology of Hormone Replacement Therapy: Diskussionen zur Postmenopausalen ... Foundation Symposium Proceedings, 13)

Springer

£57.97 08 Mar 2026
Non–Reproductive Actions of Sex Steroids: No. 191 (Novartis Foundation Symposia)
94% match

Non–Reproductive Actions of Sex Steroids: No. 191 (Novartis Foundation Symposia)

Wiley-Blackwell

£90.00 09 Mar 2026
Tissue-Specific Estrogen Action: Novel Mechanisms, Novel Ligands, Novel Therapies: 2006/1 (Ernst Schering Foundation Symposium Proceedings, 2006/1)
94% match

Tissue-Specific Estrogen Action: Novel Mechanisms, Novel Ligands, Novel Therapies: 2006/1 (Ernst Schering Foundation Symposium Proceedings, 2006/1)

Springer

£109.37 11 Mar 2026
ESTROGEN PREVENTION FOR BREAST (Cancer Etiology, Diagnosis and Treatments)
94% match

ESTROGEN PREVENTION FOR BREAST (Cancer Etiology, Diagnosis and Treatments)

£74.09 17 Feb 2026
Ein Jahrhundert endokrine Therapie des Mammakarzinoms: Von Beatson bis heute
94% match

Ein Jahrhundert endokrine Therapie des Mammakarzinoms: Von Beatson bis heute

Springer

£46.99 07 Mar 2026
Endocrine Therapy of Breast Cancer V (ESO Monographs)
94% match

Endocrine Therapy of Breast Cancer V (ESO Monographs)

Springer

£77.78 05 Mar 2026
Development and evaluation of film coated tablets of letrozole
94% match

Development and evaluation of film coated tablets of letrozole

LAP Lambert Academic Publishing

£37.11 17 Mar 2026
Estrogen Receptor and Breast Cancer: Celebrating the 60th Anniversary of the Discovery of ER (Cancer Drug Discovery and Development)
94% match

Estrogen Receptor and Breast Cancer: Celebrating the 60th Anniversary of the Discovery of ER (Cancer Drug Discovery and Development)

Humana

£149.99 23 Jan 2026
Springer Sex Hormone Replacement Therapy - Endocrine Updates 8
94% match

Springer Sex Hormone Replacement Therapy - Endocrine Updates 8

Springer

£113.48 19 Apr 2026
Biological and Hormonal Therapies of Cancer: 94 (Cancer Treatment and Research, 94)
94% match

Biological and Hormonal Therapies of Cancer: 94 (Cancer Treatment and Research, 94)

Springer

£141.36 11 Jan 2026
Androgens and Androgen Receptor: Mechanisms, Functions, and Clini Applications
94% match

Androgens and Androgen Receptor: Mechanisms, Functions, and Clini Applications

Springer

£113.94 13 Jan 2026
Biomarkers in Breast Cancer (Cancer Drug Discovery and Development)
94% match

Biomarkers in Breast Cancer (Cancer Drug Discovery and Development)

Humana

£34.06 12 Jan 2026
Springer Sex Hormone Replacement Therapy - Endocrine Updates 8
94% match

Springer Sex Hormone Replacement Therapy - Endocrine Updates 8

Springer

£120.71 19 Apr 2026
Biomarkers in Breast Cancer (Cancer Drug Discovery and Development)
94% match

Biomarkers in Breast Cancer (Cancer Drug Discovery and Development)

Humana

£144.17 12 Jan 2026